# A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults

> **NCT02218125** · PHASE1 · COMPLETED · sponsor: **Crucell Holland BV** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** MVA Mosaic
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02218125
- **Lead sponsor:** Crucell Holland BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-23
- **Primary completion:** 2015-11-30
- **Final completion:** 2015-11-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02218125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02218125, "A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02218125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*